COVID-19 and antibiotic resistance: Parallel pandemics and different intercessions. | ||||
| Microbes and Infectious Diseases | ||||
| Article 6, Volume 2, Issue 1, February 2021, Page 15-24 PDF (281.13 K) | ||||
| Document Type: Review Article | ||||
| DOI: 10.21608/mid.2020.49732.1087 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Adam Mustapha   1; Jamilu Nikau2; Tijani Isa1
| ||||
| 1Department of Microbiology, Faculty of Science, University of Maiduguri, Nigeria. | ||||
| 2Federal Ministry of Health, Abuja, Nigeria | ||||
| Abstract | ||||
| Coronavirus virus disease 2019 (COVID-19) is one of the challenges to the global public health. With COVID-19 impacts across all sectors, the most glaring one is its impact on antibiotic resistance, another silence pandemic. Antibiotic resistance is at a crossroads of becoming a major killer and the emergence of COVID-19 pandemic aggravate the threat, due to excessive and extensive use of antibiotics in the treatment package of COVID-19 despite being a viral pneumonia and for prophylaxis to prevent bacterial co-infection. Low bacterial co-infections were associated with COVID-19, but large antibiotics were employed, this challenged the principles of antibiotic stewardship, thus, further complicate the antibiotic stewardship guidelines. This review revolves to highlight the effect of COVID-19 pandemic and its impacts on bacterial co-infections as well as how it fuels the already existing silent pandemic; antibiotic resistance which is waiting to unleash its effect on public health and socioeconomic sectors. While there is increase focus on COVID-19 pandemic, the review urged that focus should not be taken off on antibiotic resistance. | ||||
| Keywords | ||||
| COVID-19 pandemic; antibiotic resistance; antibiotic stewardship; co-infection; viral pneumonia | ||||
|
Statistics Article View: 788 PDF Download: 693 |
||||
